Absci Competitors and Similar CompaniesClear all
Absci's competitors and similar companies include Cingulate and HilleVax.
 Cingulate Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety. |  HilleVax HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. | ||
Founding Date | Founding Date 2011 | Founding Date 2021 | Founding Date 2020 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Vancouver, US HQ Belgrade, RS Zug, CH New York, US | Locations Kansas City, US HQ Morristown, US | Locations Boston, US HQ |
Employees | Employees 1561% increase | Employees 13 | Employees 31 |
Valuation ($) | Valuation ($) 487.2 m | Valuation ($) 13.2 m | Valuation ($) 95.1 m |
Financial | |||
Net income | Net income ($115.2m) (FY, 2025) | Net income ($22.4m) (FY, 2025) | Net income ($147.3m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Cingulate
HQ
Kansas City, US
Employees
13
Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety.
View companyHilleVax
HQ
Boston, US
Employees
31
HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines.
View company